Home
About
Profile
Milestone
Honor
Culture
Responsibility
Products
Prevention and treatment of heart failure
Cardiogenic stroke
Valvular disease
Intervention consumables
Technology platform
R&d results
Intellectual property
Industry-university-research cooperation
News
Company dynamics
Industry information
Application case
HR
Talent concept
Talent recruitment
Contact
Contact Information
Online message
DOCS VALVE®Transcatheter aortic Valve Replacement System (in Development)
The prevalence of valve disease in China is 3.8%, about 25 million people. According to industry reports, the number of patients with aortic stenosis and aortic regurgitation in China in 2022 is about 4.65 million and 4.05 million, respectively. With the aging trend of China's population, heart valve disease will increase, if not timely standardized treatment, the mortality rate of 2 years can reach 50%, and the mortality rate of 5 years is as high as 97%.
+
More
ArrowCross™Atrial septal puncture system
The atrial septal puncture system is tubular, which is composed of catheter sheath, dilator, J-shaped guide wire and puncture needle.
Astross™Cardiac occluder delivery system
The conveying system of heart occluder is a tubular structure, which is composed of sheath tube, loader, expander, adapter and conveying steel cable.
Arkcess® Left ventricular guide wire
The left ventricular guide wire consists of a core wire and a winding wire with a polytetrafluoroethylene hydrophobic coating on the surface.
©2023 Wuhan Vickor Medical Technology Co., Ltd.
This site already supports IPV6 access | SEO | Business License
